Xtandi 40 MG capsule 120S

Ended Awarded

Contract number
SPE2DB23FX7Q9
Awardee
Awarding agency
Obligated
$17,245

Award facts

Contract value 100% obligated
$17,245.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. valued at seventeen thousand two hundred forty-five dollars and forty cents ($17,245.40) to supply one hundred twenty (120) capsules of XTANDI 40 MG CAPSULE. Performance will take place in Park Ridge, Illinois with completion by May 5, 2023. The firm fixed price contract was awarded on May 4, 2023 without a set-aside designation. As the DLA supports military treatment facilities, this order for the prostate cancer drug will aid in the Agency's mission to provide pharmaceuticals and medical supplies to military healthcare providers and beneficiaries.

Quick answers

Who was awarded contract SPE2DB23FX7Q9?

SPE2DB23FX7Q9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 4, 2023.

How much is contract SPE2DB23FX7Q9 worth?

The government has obligated $17,245 on SPE2DB23FX7Q9.

Is contract SPE2DB23FX7Q9 an order under another contract?

Yes. SPE2DB23FX7Q9 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.

Was contract SPE2DB23FX7Q9 competed?

The extent of competition for SPE2DB23FX7Q9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award